+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of prognostic inflammatory factors in colorectal liver metastases



Identification of prognostic inflammatory factors in colorectal liver metastases



Bmc Cancer 14: 542



The modified Glasgow Prognostic Score (mGPS) has been reported to be an important prognostic indicator in a number of tumor types, including colorectal cancer (CRC). The features of the inflammatory state thought to accompany elevated C-reactive protein (CRP), a key feature of mGPS, were characterized in patients with colorectal liver metastases. Additional inflammatory mediators that contribute to prognosis were explored. In sera from 69 patients with colorectal liver metastases, a panel of 42 inflammatory mediators were quantified as a function of CRP levels, and as a function of disease-free survival. Multivariate statistical methods were used to determine association of each mediator with elevated CRP and truncated disease-free survival. Elevated CRP was confirmed to be a strong predictor of survival (HR 4.00, p = 0.001) and recurrence (HR 3.30, p = 0.002). The inflammatory state associated with elevated CRP was comprised of raised IL-1β, IL-6, IL-12 and IL-15. In addition, elevated IL-8 and PDGF-AB/BB and decreased eotaxin and IP-10 were associated with worse disease-free and overall survival. Elevated CRP is associated with a proinflammatory state. The inflammatory state is an important prognostic indicator in CRC liver metastases. The individual contributions of tumor biology and the host to this inflammatory response will require further investigation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053670096

Download citation: RISBibTeXText

PMID: 25069793

DOI: 10.1186/1471-2407-14-542


Related references

Tu1780 Identification of Prognostic Factors Following Resection of Colorectal Liver Metastases in the Modern Era of Treatment. Gastroenterology 148(4): S-1180-S-1181, 2015

Prognostic factors in the evaluation of colorectal liver metastases. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 76(6): 535-6 538-42, 2005

Prognostic factors for cryotherapy of colorectal liver metastases. European Journal of Surgical Oncology 30(1): 34-40, 2004

Comparison of the prognostic value of systemic inflammatory indices in patients with resectable colorectal liver metastases. Hpb 18: E722-E723, 2016

Prognostic factors after resection of colorectal cancer liver metastases. Cirugia Espanola 85(1): 32-39, 2009

Prognostic factors in curatively resected colorectal liver metastases. Virchows Archiv 435(3): 284, 1999

Prognostic factors in liver resection for metastases of colorectal cancer. Langenbecks Archiv fuer Chirurgie 372: 887, 1987

Liver resection for colorectal metastases Results and prognostic factors. British Journal of Cancer 78(2): 152, 1998

Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population. World Journal of Surgery 42(4): 1073-1084, 2018

Analysis of prognostic factors in 300 colorectal cancer patients with liver metastases. Zhonghua Zhong Liu Za Zhi 31(3): 220-222, 2009

Resection of liver metastases of colorectal carcinoma: Results and prognostic factors. Chirurg 64(4): 283-287, 1993

Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepato-Gastroenterology 47(31): 239-246, 2000

Prognostic factors after resection of colorectal liver metastases: from morphology to biology. Future Oncology 9(1): 45-57, 2013

Preoperative tumor markers as prognostic factors of colorectal liver metastases. Hepato-Gastroenterology 56(90): 317-320, 2009

Resection of liver metastases of colorectal cancers. Results and prognostic factors. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 64(4): 283-7; Discussion 288-9, 1993